Neurological Biomarkers 2018-2025


2018-12-30 03:46:42
121827

 

Neurological Biomarkers Market is Projected to Mask a Remarkable CAGR of 11.1% over the Forecast period.

Research Methodology:

Primary research: Interviews of various industry experts and supplement this with the best secondary sources for each study. The break-up of primary research is as follows:

By Company Type-  Tier 1: 40%, Tier 2: 32% & Tier 3: 28%

By Designation: C-Level Executives: 38%, Directors: 24% & Managers: 28%.

By Region- North America: 27%, Europe: 22%, Asia Pacific:30%, Rest of World:21%

Secondary research: Secondary sources and exclusive data and analytics with in-depth reporting.

Data Triangulation: After gaining insights from primary and secondary research, the research team analyzes data about the latest trends and key issues in reference to each country and industry and present it in report.

Market Segmentation:

By Type:

Imaging Biomarkers

Metabolomics Biomarkers

Proteomic Biomarkers

Genomics Biomarkers

By Application:

Spinal Muscular Atrophy (SMA)

Multiple Sclerosis

Depression

Schizophrenia

Huntington Disease

Parkinson Disease

Alzheimer Disease

By End Users:

Hospitals

Research Institutes

Diagnostic Centers

Regional Segmentation:

North America (U.S. & Canada), Europe (Germany, UK, France, Italy, Spain, Russia, Poland, Rest of Europe), Asia Pacific (China, India, Japan, South Korea, Malaysia, Singapore, Australia, Rest of Asia-Pacific), Latin America (Brazil, Mexico, Rest of Latin America) and Middle East & Africa (GCC, South Africa, North Africa and Rest of Middle East & Africa)

Market Size & Forecast:

The market of neurological biomarkers is flourishing at a CAGR (Compound Annual Growth Rate) of 11.1% over the forecast period. The market is estimated to reach at an exponential value of USD 8,179.2 Million at the end of 2025.   

Regionally, North America region dominated the market of neurological biomarkers in 2017. Apart from this, Asia-Pacific region is projected to showcase considerable CAGR of over the forecast period due to large population base, along with increase in incidental rates of neurological abnormalities.

Market Drivers, Trends, Opportunities and Restraints:

Drivers:

Rise in focus on developing cost-effective biomarker testing coupled with upsurge in demand for noninvasive diagnostic techniques for Alzheimer’s and Parkinson’s disease are some of the factors triggering the growth of neurological biomarkers market.  

Research Scope

- Overview of Main Industry Events and Analysis of Their Market Impact

- Executive Summary

- Market Drivers, Trends, Challenges and Opportunities

- Market Size and Forecast Projections

- Estimating Market Access in Each Region and Implications of the Emerging Technologies in the Market

- Macroeconomic Indicators of Various Countries Impacting the Growth of the Market

- Extensive Coverage of Industry Players including Recent Product Launches and Market Activities

- BCG Growth Share Matrix

- Porter’s Five Force Analysis

 

Reasons to Buy

The report will facilitate you to:

- Cultivate and design your in-licensing and out-licensing strategies through a review of marketed products and technologies.

- Develop business tactics by understanding the trends molding and thriving the market.

- Drive revenues by considering the vital trends, pioneering products and technologies, market segments and companies likely to impact the market in the future.

- Formulate effective sales and marketing strategies by examining the competitive landscape and by evaluating the performance of various competitors.

- Recognize emergent players with potentially strong product portfolios and develop effective counter-tactics to gain a competitive advantage.

- Unify your sales and marketing labors by recognizing the market segments that present utmost opportunities for consolidations, investments and strategic partnerships.

Market Players:

Abbott Laboratories, Myriad RBM, Proteome Sciences, Thermo Fisher Scientific, Athena Diagnostics, Immunarray Pvt. Ltd., Quanterix Corporation, Diagenic ASA, Psynova Neurotech, and Bio-Rad Laboratories are some of the major players dominating the neurological biomarkers market globally.

 

    Pricing

Quick Buy Add to cart

Contact Us:

info@prmsolution.com